Red Cell Partners

Red Cell Partners is an incubation and investment platform focused on building rapidly scalable, technology-led companies that address critical challenges in healthcare and defense sectors. The firm employs a flexible model, directly incubating, investing in, and acquiring companies with the potential to transform these industries through technological innovation. Their mission is to develop powerful tools and solutions to tackle the nation's most pressing problems.

The firm's investment strategy encompasses a wide range of stages, from pre-seed to late-stage investments, including buyouts and distressed situations. Red Cell Partners has a strong geographical focus on the United States, aiming to support and scale companies that can make a significant impact within the country. Their portfolio spans various industries, including healthcare, cybersecurity, national security, and technology, reflecting their commitment to fostering innovation across critical sectors.

Since its inception, Red Cell Partners has been actively involved in launching and funding numerous companies. Notable investments include Eyris, a digital infrastructure platform for data protection and cybersecurity, and Savoy Life, a virtual healthcare platform for long-term care. These initiatives underscore the firm's dedication to advancing technological solutions that enhance security and healthcare services. Through strategic investments and incubations, Red Cell Partners continues to drive innovation and address complex challenges in healthcare and defense sectors.